The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
SYDNEY, AU, Feb 15, 2023 ̵ […]
InaVac gets emergency approval from BPOM
Surabaya, East Java, Indonesia […]
AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share
HONG KONG, Oct 5, 2022 – […]
Bio Farma secures multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)
BANDUNG, INDONESIA, Oct 2, 202 […]
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK
HONG KONG, Sep 23, 2022 – […]
Indonesia’s Bio Farma ready to produce ‘IndoVac’ Covid-19 vaccines
BANDUNG, INDONESIA, Sep 12, 20 […]
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Bandung, W Java, Indonesia, Se […]
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
SEOUL, S.KOREA, Jul 13, 2022 & […]
Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully
HONG KONG, Apr 7, 2022 – […]
Recbio Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
HONG KONG, Mar 21, 2022 – […]
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children (6-11 Years)
Cambridge, MA, Feb 17, 2022 &# […]
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
HANGZHOU, CHINA, Jan 12, 2022 […]